PolyPid Appoints New Oncology Advisory Board Member

NEXT STORY
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings
PREV STORY
Codiak Reports Positive Initial Data for exoSTING™ Phase 1/2 Trial Indicating Tolerability, Immune Activation, and Evidence of Tumor Shrinkage in Injected and Non-Injected Tumors in the First Three Dose Escalation Cohorts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Protech Home Medical Announces Closing of $31.8 Million Short Form Prospectus Offering (Including Full Exercise of the Over-Allotment Option) and Concurrent Private Placements

author_avatar
NASDAQ Market News

Avadel Pharmaceuticals Announces Planned Reduction of French Workforce

DUBLIN, Ireland, March 30, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced ...

author_avatar
NASDAQ Market News

Targovax to present at DNB healthcare conference

Oslo, Norway, 13 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company ...

author_avatar
NASDAQ Market News